Drug Characteristics
  • Formulation

    200mg tablet

    Coformulated with tenofovir as Truvada

    Coformulated with efavirenz and tenofovir as Atripla  *

    Coformulated with rilpivirine and tenofovir as Eviplera

    Coformulated with cobicistat, elvitegravir, and tenofovir as Stribild

  • Dose

    200mg daily in one dose

    infant 2 mg/kg as a single dose (with 13 mg/kg of TDF) within 12 hours after birth

  • Side Effects
  • Interactions

    Active against hepatitis B.  Risk of flare if treatment interupted

  • Renal

    reduce dose if eGFR less than 50 mL/minute/1.73 m2

  • Hepatic

    Active against hepatitis B. Risk of flare if treatment interupted

  • Pregnancy

    FDA catagory B should be used during pregnancy only if clearly needed.

  • Other Information